Cogentis Therapeutics

Developer of therapeutics that prevent neurodegeneration and restore brain function

placeBaltimore, Maryland, United States calendar_todayFounded 2015 groups154 employees language cogentistherapeutics.com

Registered entities

Investor mix

4 investors on record; lead investors include SBIR.

Investor typeCountShare
Venture capital125%
Accelerator & incubator125%
Other / undisclosed250%
Coming soon